Aperam released H1 numbers. Sales reached US$2,197m (-12.8%), EBITDA US$235m (-18.4%), EBIT US$153m (-21.5%) and net income US$102m (-5.6%). Free cash flow (ex-dividend) amounted to US$93m (-8.8%). Net debt at the end of Q2 was US$280m vs US$338m in Q1 and US$316m at year-end 2015. The group expects Q3’s EBITDA to be similar to Q2’s, which would imply c. US$360m in EBITDA over 9 months, with a further decrease in net debt.
27 Jul 2016
H1 results: decent with some hopes for improvement
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
H1 results: decent with some hopes for improvement
Aperam SA (APAM:WBO) | 0 0 (-0.4%) | Mkt Cap: 3,664m
- Published:
27 Jul 2016 -
Author:
Fabrice Farigoule -
Pages:
3
Aperam released H1 numbers. Sales reached US$2,197m (-12.8%), EBITDA US$235m (-18.4%), EBIT US$153m (-21.5%) and net income US$102m (-5.6%). Free cash flow (ex-dividend) amounted to US$93m (-8.8%). Net debt at the end of Q2 was US$280m vs US$338m in Q1 and US$316m at year-end 2015. The group expects Q3’s EBITDA to be similar to Q2’s, which would imply c. US$360m in EBITDA over 9 months, with a further decrease in net debt.